Key statistics
As of last trade, Absci Corp (ABSI:NSQ) traded at 2.44, 21.39% above the 52 week low of 2.01 set on Apr 04, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 2.62 |
|---|---|
| High | 2.62 |
| Low | 2.40 |
| Bid | 2.43 |
| Offer | 2.44 |
| Previous close | 2.60 |
| Average volume | 3.39m |
|---|---|
| Shares outstanding | 150.37m |
| Free float | 136.41m |
| P/E (TTM) | -- |
| Market cap | 396.98m USD |
| EPS (TTM) | -0.903 USD |
Data delayed at least 15 minutes, as of Feb 12 2026 20:10 GMT.
More ▼
- Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference
- Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization
- Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research
- Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia
- Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results
- Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025
- Absci to Participate in Upcoming Investor Conferences
- Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial
- Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD
- Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg
More ▼
